CCL3 and B-cell chronic lymphocytic leukemia: Abnormalities of bone metabolism in CLL are associated with elevated serum levels of tumor necrosis factor α, interleukin-6, interleukin-8, and chemokine (C-C motif) ligand 3 (CCL3) [79,80,81,82].